“Asthma Biologics: Underuse, Overuse, and Best Use?”

Uncontrolled asthma is a significant problem worldwide . It is important to acknowledge that many patients with uncontrolled asthma can be brought under control using medications that have been available now for decades. Unfortunately, nonadherence to regular use of ICS/LABA is incredibly common and solving the complex reasons for nonadherence is not straightforward. Recently, we have the addition of 5 injected asthma biologic medications which are intended for patients who are not controlled with ICS/LABA and specific features such as IgE-high (omalizumab), Eosinophils-high (benralizumab, mepolizumab, and reslizumab), and/or Th2-high (dupilumab).

https://ift.tt/2ExRsMK